Ground-breaking tech to make chemical reactions reproducible & analysable, building huge data libraries of the results. Tech application will be used primarily to save pharma costs when developing new drugs.
Nobel prize winning Scientist Frances Arnold has had to retract her prize winning paper as the results cannot be replicated from current data. Had they used DeepMatter this work could have been replicable…
Seriously huge untapped market, especially in the drug development sector. This is still a penny stock (trades at around 2p per share!). How long would you wait as a pharma boss before taking this tech off the table from your competitors?
Out of interest, if I was to consider buying this (or other stock) that aren’t currently offered on Freetrade, which brokers would you recommend (asking anyone - I’m new to all this!)
Thanks for any advice!
I took a closer look at this after my previous comment. Their market cap is £16M. They’re practically pre-revenue, their only revenue has been from an acquisition. Although their H1 2019 results indicated they should have revenue in H2.
There are a handful of trades a day, I would not trade something this illiquid without using limit orders, something Freetrade is yet to offer. I do invest in risky pre-revenue companies (hello Freetrade), but only when there’s S/EIS tax breaks involved.
This stock was available to buy but now its listed as only available to premium members. Does free-trade change buy options on a monthly basis as I’m not wanting to pay 9.99 a month just to buy Into deepmatter.